Case 4 Flashcards
Why is endothelium significant in the clotting cascade?
Synthesis of von Willibrand factor (haemostasis) and PGI2 (antithrombotic, prevents aggregation of platelets)
Production of nitric oxide by endothelial cells
Ligand binds to GPCR. Activation of PLC which converts PIP2 to IP3 and DAG.
These molecules cause an increase in intracellular Ca2+.
Ca2+ binds to calmodulin and activates eNOS (endothelial NO synthase).
eNOS synthesises NO from L-arginine - BH4 is an essential cofactor.
How is NO production maintained when stimulus is prolonged?
Increased transcription of eNOS.
How do endothelial cells in the blood vessel walls respond to mechanical force?
Glycocalyces project into lumen of vessel and are attached to the cytoskeleton. Movement of glycocalyx activates Ca2+ channels. Increased Ca2+ intracellularly causing eNOS activation. NO production and vasodilation.
How does NO cause vasodilation?
Activation of cGMP and therefore PKG. PKG inhibits Ca2+ influx into sarcoplasm and promotes Ca2+ efflux out of sarcoplasm.
(PKG also inhibits IP3 mediated Ca2+ influx pathway)
Paracrine effects of Nitric Oxide
Decreased platelet aggregation + decreased monocyte and platelet adhesion
Decreased LDL oxidation - fewer atheromatous plaques formed.
Decreased expression of adhesion molecules
Decreased smooth muscle proliferation and contraction.
Changes in vascular endothelial cells with age
Older endothelial cells generate more reactive oxygen species.
ROS react with NO, reducing its bioavailability and producing peroxinitrites which have detrimental effects on cell functions.
Endothelial dysfunction - reduced vasodilation
Changes to blood vessels which occur as a result of endothelial dysfunction
Thickening of media and narrowing of lumen (due to vascular inflammation and remodelling)
Increased stiffness and potentially calcification.
Endothelium derived contracting factors
Usually prostanoids which cause contraction.
Has a greater effect when NO production is impaired.
Risk factors for atherosclerosis
Smoking Hyperlipidaemia Diabetes Hypertension Shear stress (occurs at sites where blood changes speed/direction)
Formation of an atheromatous plaque
Circulating LDL and monocytes cross the vascular endothelium into the intima.
LDLs become oxidised (oxidised LDL promotes increased permeability of endothelium)
Monocytes mature into macrophages.
Macrophages take up OxLDL and become foam cells.
Foam cells release inflammatory signals to recruit more leukocytes to site.
Foam cells accumulate and become apoptotic - releasing LDL and forming a lipid deposit. This also causes proinflammatory signal release, so further influx of inflammatory cells.
Finally, smooth muscle cells dedifferentiate, migrate and proliferate into intima. Secrete ECM forming a fibrous cap.
Factors responsible for monocyte adhesion to vascular endothelial cell membrane
P selections and E selectins
Factors responsible for monocyte migration across vascular endothelial cell membrane into intima
MCP-1 and OxLDL
Why does atheromatous plaque formation occur at regions where blood changes direction/speed?
Part of the wall will experience a decrease in shear stress - less eNOS activation.
Therefore, less endothelial repair.
More ROS generated, leukocyte adhesion, LDL entering intima and inflammation.
When the plaque is formed, the region of disturbed flow is amplified.
Eccentric plaque
Does not occupy the whole circumference
Concentric plaque
Occupies the whole circumference
Factors which affect stability of atheromatous plaques
Size - larger plaques contain more soft material and are therefore less stable.
Lipid content - higher ratio of lipid to fibrous cap is less stable
Bleeding inside the cap - increased pressure and therefore more susceptible to rupture.
Endothelial contracting factors
H2O2 Prostanoids Angiotensin II Endothelin - I Thromboxane A2 Superoxide anion
Endothelial relaxing factors
NO PGI2 H2O2 Adenosine Epoxyeicosatrienicacids (EETs)
Endothelium Derived Hyperpolarising Factor
Compensatory mechanism - cause vasodilation when NO bioavailability is compromised due to superoxide production.
Significant role in disease states e.g. hypertension
Left Anterior Descending coronary artery supplies…
Right and left ventricles and interventricular septum
Left Marginal coronary artery supplies…
Left ventricle
Left circumflex coronary artery supplies…
Left atrium and ventricle
Right Coronary artery supplies…
Right atrium and ventricle
Right Marginal Coronary artery supplies…
Right ventricle and apex
Posterior Interventricular coronary artery supplies…
Right and left ventricles and interventricular septum
RCA occlusion causing MI on an ECG
Inferior MI
ST elevation in II, III and aVF
LAD occlusion causing MI on an ECG
Septal MI - ST elevation in V1 and V2
Anterior MI - ST elevation in V3 and V4
LCx occlusion causing MI on an ECG
Lateral MI - ST elevation in I, aVL, V5 and V6
Composition of lipoproteins
Lipid core - Triglyceride and cholesteryl esters
Surface coat - phospholipid, unesterified cholesterol and apolipoproteins.
Function of HDL
Transport cholesterol back to liver
Apolipoprotein associated with HDL
ApoA1 (receptor ligand)
Apolipoprotein associated with LDL
ApoB100 (receptor ligand)
Function of LDL
Transport cholesterol from liver to tissues
Function of IDL
Transport cholesterol from liver to tissues
Apolipoprotein associated with IDL
ApoE (receptor ligand)
Function of VLDL
Transport cholesterol from liver to tissues
Apolipoprotein associated with VLDL
ApoCII (cofactor lipoprotein lipase)
Function of chylomicrons
Transport triglyceride from gut to liver
Apolipoprotein associated with chylomicrons
ApoB48 (Receptor ligand)
What are apolipoproteins?
Proteins that bind lipids to form lipoproteins - transport lipids through lymphatics and circulatory system.
Exogenous lipid transport pathway
Fat and cholesterol absorbed from GI tract assembled to form chylomicrons.
Chylomicrons carried in the bloodstream, deposit their fats when they meet tissues expressing Lipoprotein lipase (e.g. Adipose)
Remaining chylomicron remnant used to form empty HDL or are removed at the liver by binding of ApoE to their receptor.
Endogenous lipid transport pathway
Fatty acids in liver (transported here OR synthesised) packaged into VLDLs.
VLDLs carried in the bloodstream, deposit their fats when they meet tissues expressing Lipoprotein lipase (e.g. Adipose)
They are now called IDLs, which are absorbed into liver, broken down into LDLs by hepatic lipase.
Circulating LDLs are absorbed into various tissues on binding to their receptors.
HDL created as a biproduct.
Reverse cholesterol transport pathway
Too much cholesterol in peripheral tissue causes activation of ABCA1 receptor.
HDL interacts with this receptor causing LDL to be returned to the liver.
Antiatherogenic
When do patients with atherosclerosis become symptomatic?
Development of fibrous cap - increased risk of complications such as plaque rupture, thrombosis and haemorrhage
Familial Hypercholesterolaemia
Insufficient (heterozygote) or no (homozygote) ApoB100 receptor for LDL to bind to so that it is removed from circulation.
Autosomal dominant.
Causes development of cardiovascular disease 20yrs early.
Treatment of familial hypercholesterolaemia
Statins
Clinical signs for hypercholesterolaemia
Xanthelasma
Tendon Xanthoma
Corneal Arcus
PCSK9
Enzyme which binds to LDL receptor and breaks it down so that it is unable to remove LDLs.
Inhibited by certain drugs to lower serum cholesterol.
Cholesterol synthesis
Acetyl coA converted to HMG CoA.
HMG CoA converted to mevalonate by HMG CoA Reductase.
Mevalonate then converted to cholesterol
ADRs of statins
Nasopharyngitis Hyperglycaemia Headache Pharyngolaryngeal pain Epistaxis GI disorders Musculoskeletal and connective tissue disorders (Myositis in 2-3%)
Contraindications of statins
Active liver disease
Raised AST or ALT
Pregnancy or breastfeeding
Most commonly used statin
Atorvastatin
Statin used in children
Pravastatin
Indication for statins
Primary prevention - patients at high risk of CVD
Secondary prevention - patients who have had an MI already
Dicrotic notch
Sudden dip in pressure in aorta due to backflow of blood in artery as valve closes (AKA Incisura)
Effect of atherosclerosis on dicrotic notch
Larger - less compliant blood vessel, cannot compensate for pressure changes as quickly.
S1
Atrioventricular valve closure (“Lub”)
S2
Aortic/Pulmonary valve closure (“Dub”)
S3
“Ventricular gallop” - a large amount of blood striking a stiffened left ventricle
S4
Left atrium contracts against a stiffened ventricular wall due to reduced compliance (Hypertrophy or MI)
Area of pressure volume loop represents…
Net work done
Ejection fraction
Stroke volume/End Diastolic Volume (peak volume)
Heart sound which corresponds with end diastolic pressure/volume
S1
Heart sound which corresponds with end systolic pressure/volume
S2
At what point in the cardiac cycle is S4 heard?
Just before S1, at the end of diastole
Factors which increase preload
Increased blood volume
Increased skeletal muscle pump activity
Factors which increase afterload
Hypertension
Increased peripheral resistance (atherosclerosis and arteriosclerosis
Aortic stenosis
Changes to pressure-volume loop as a result of increased preload
Taller and shifted to the right
Increased pressures and volumes generated
Changes in pressure-volume loop as a result of increased afterload
Taller
Greater pressures generated by the same volume of fluid
Changes in pressure-volume loop as a result of increased inotropy
Taller and shifted to the left
ESPVR is steeper since more pressure can be generated by a smaller volume of fluid.
Orthostatic Hypotension
Pooling of blood in veins of legs when individual changes from supine to standing.
Decrease in venous return, therefore decreased stroke volume, cardiac output and arterial pressure.
Brief moment of cerebral ischaemia before autoregulation compensates for this.
Baroreceptors are expressed in…
Carotid sinus and aortic arch walls
How do baroreceptors detect blood pressure?
Express stretch sensitive TRP family channels which are non selectively permeable to cations (Ca2+, Na+_
Increased stretching, causes increased entry of cations into afferent neurons. Many action potentials generated